Interleukin-10 Controls the Onset of Irreversible Septic Shock

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2002 Jul 16

PMID 12117955

Citations 69

Authors

Samir Q Latifi

Mary Ann ORiordan

Alan D Levine

Affiliations

Soon will be listed here.

Abstract

Lethality from sepsis is believed to be mediated by a proinflammatory cytokine cascade, yet blocking the proinflammatory cytokines tumor necrosis factor alpha (TNF-alpha) and interleukin-1 (IL-1) fails to prevent mortality in human disease and a mouse model of sepsis induced by cecal ligation and puncture (CLP). The role of the antiinflammatory cytokine IL-10 in the CLP model of sepsis is unclear, with either protective or harmful effects demonstrated, depending upon the time of intervention. We therefore hypothesize that IL-10 functions as a temporal regulator of the transition from early reversible sepsis to the late phase of irreversible shock. Transition from reversible sepsis to irreversible shock in the CLP model was defined as the time when removal of the necrotic cecum by rescue surgery is no longer effective. We subjected IL-10-deficient (IL-10(-/-)) and wild-type (IL-10(+/+)) mice to CLP and monitored the progression of sepsis, the onset of irreversible shock, and mortality. Onset of lethality in IL-10(-/-) mice occurred significantly earlier than in IL-10(+/+) mice and was associated with 15-fold-higher serum levels of TNF-alpha and IL-6. Consistent with these findings, the efficacy of rescue surgery after lethal CLP is lost 10 h earlier in IL-10(-/-) mice than in IL-10(+/+) mice. Treatment with recombinant human IL-10 5 h after CLP significantly improved survival and lengthened the therapeutic window for rescue surgery in both strains of mice. These results demonstrate that IL-10 controls the onset of irreversible septic shock after CLP.

Citing Articles

Development of Anti-Inflammatory Agents Utilizing DC-SIGN Mediated IL-10 Secretion in Autoimmune and Immune-Mediated Disorders: Bridging Veterinary and Human Health.

Baek H, Yang S, Kim S, Lee Y, Park H, Park M Int J Mol Sci. 2025; 26(5).

PMID: 40076949 PMC: 11901132. DOI: 10.3390/ijms26052329.

CTSO and HLA-DQA1 as biomarkers in sepsis-associated ARDS: insights from RNA sequencing and immune infiltration analysis.

Shen Y, Yao Y, Li H, Li Y, Hu Y BMC Infect Dis. 2025; 25(1):326.

PMID: 40055592 PMC: 11887161. DOI: 10.1186/s12879-025-10726-8.

Delayed macrophage targeting by clodronate liposomes worsens the progression of cytokine storm syndrome.

Khanna K, Eul E, Yan H, Faccio R Front Immunol. 2024; 15:1477449.

PMID: 39530102 PMC: 11550973. DOI: 10.3389/fimmu.2024.1477449.

Protective Effects of a Dihydrodiazepine Against Endotoxin Shock Through Suppression of TLR4/NF-κB/IRF3 Signaling Pathways.

Hanieh H, Alfwuaires M, Abduh M, Abdrabu A, Qinna N, Alzahrani A Inflammation. 2024; .

PMID: 39400777 DOI: 10.1007/s10753-024-02160-w.

The iNKT cell ligand α-GalCer prevents murine septic shock by inducing IL10-producing iNKT and B cells.

Park Y, Lee S, Kim T, Park H, Van Kaer L, Hong S Front Immunol. 2024; 15:1457690.

PMID: 39355237 PMC: 11442275. DOI: 10.3389/fimmu.2024.1457690.

References

Reinhart K, Menges T, Gardlund B, Harm Zwaveling J, Smithes M, Vincent J . Randomized, placebo-controlled trial of the anti-tumor necrosis factor antibody fragment afelimomab in hyperinflammatory response during severe sepsis: The RAMSES Study. Crit Care Med. 2001; 29(4):765-9. DOI: 10.1097/00003246-200104000-00015. View

Sewnath M, Olszyna D, Birjmohun R, Ten Kate F, Gouma D, van der Poll T . IL-10-deficient mice demonstrate multiple organ failure and increased mortality during Escherichia coli peritonitis despite an accelerated bacterial clearance. J Immunol. 2001; 166(10):6323-31. DOI: 10.4049/jimmunol.166.10.6323. View

Hollenberg S, Dumasius A, Easington C, Colilla S, Neumann A, Parrillo J . Characterization of a hyperdynamic murine model of resuscitated sepsis using echocardiography. Am J Respir Crit Care Med. 2001; 164(5):891-5. DOI: 10.1164/ajrccm.164.5.2010073. View

Baker C, Chaudry I, Gaines H, Baue A . Evaluation of factors affecting mortality rate after sepsis in a murine cecal ligation and puncture model. Surgery. 1983; 94(2):331-5. View

Beutler B, Milsark I, Cerami A . Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 1985; 229(4716):869-71. DOI: 10.1126/science.3895437. View

Ohlsson K, Bjork P, Bergenfeldt M, Hageman R, Thompson R . Interleukin-1 receptor antagonist reduces mortality from endotoxin shock. Nature. 1990; 348(6301):550-2. DOI: 10.1038/348550a0. View

Sullivan J, Kilpatrick L, Costarino Jr A, Lee S, Harris M . Correlation of plasma cytokine elevations with mortality rate in children with sepsis. J Pediatr. 1992; 120(4 Pt 1):510-5. DOI: 10.1016/s0022-3476(05)82476-x. View

Eskandari M, Bolgos G, Miller C, Nguyen D, Deforge L, Remick D . Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia. J Immunol. 1992; 148(9):2724-30. View

Howard M, Muchamuel T, Andrade S, Menon S . Interleukin 10 protects mice from lethal endotoxemia. J Exp Med. 1993; 177(4):1205-8. PMC: 2190971. DOI: 10.1084/jem.177.4.1205. View

10.

Papaioannou V, Fox J . Efficacy of tribromoethanol anesthesia in mice. Lab Anim Sci. 1993; 43(2):189-92. View

11.

McMasters K, Peyton J, Hadjiminas D, Cheadle W . Endotoxin and tumour necrosis factor do not cause mortality from caecal ligation and puncture. Cytokine. 1994; 6(5):530-6. DOI: 10.1016/1043-4666(94)90081-7. View

12.

Meduri G, Headley S, Kohler G, Stentz F, Tolley E, Umberger R . Persistent elevation of inflammatory cytokines predicts a poor outcome in ARDS. Plasma IL-1 beta and IL-6 levels are consistent and efficient predictors of outcome over time. Chest. 1995; 107(4):1062-73. DOI: 10.1378/chest.107.4.1062. View

13.

Lundblad R, Giercksky K . Effect of volume support, antibiotic therapy, and monoclonal antiendotoxin antibodies on mortality rate and blood concentrations of endothelin and other mediators in fulminant intra-abdominal sepsis in rats. Crit Care Med. 1995; 23(8):1382-90. DOI: 10.1097/00003246-199508000-00012. View

14.

Kato T, Murata A, Ishida H, Toda H, Tanaka N, Hayashida H . Interleukin 10 reduces mortality from severe peritonitis in mice. Antimicrob Agents Chemother. 1995; 39(6):1336-40. PMC: 162737. DOI: 10.1128/AAC.39.6.1336. View

15.

Berg D, Kuhn R, Rajewsky K, Muller W, Menon S, Davidson N . Interleukin-10 is a central regulator of the response to LPS in murine models of endotoxic shock and the Shwartzman reaction but not endotoxin tolerance. J Clin Invest. 1995; 96(5):2339-47. PMC: 185885. DOI: 10.1172/JCI118290. View

16.

van der Poll T, Marchant A, Buurman W, Berman L, Keogh C, Lazarus D . Endogenous IL-10 protects mice from death during septic peritonitis. J Immunol. 1995; 155(11):5397-401. View

17.

Huhn R, Radwanski E, OConnell S, Sturgill M, Clarke L, Cody R . Pharmacokinetics and immunomodulatory properties of intravenously administered recombinant human interleukin-10 in healthy volunteers. Blood. 1996; 87(2):699-705. View

18.

Doughty L, Kaplan S, Carcillo J . Inflammatory cytokine and nitric oxide responses in pediatric sepsis and organ failure. Crit Care Med. 1996; 24(7):1137-43. DOI: 10.1097/00003246-199607000-00012. View

19.

Gazzinelli R, Wysocka M, Hieny S, Scharton-Kersten T, Cheever A, Kuhn R . In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. J Immunol. 1996; 157(2):798-805. View

20.

Wilson M, Chou M, Spain D, Downard P, Qian Q, Cheadle W . Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis. J Trauma. 1996; 41(4):622-7. DOI: 10.1097/00005373-199610000-00005. View